Cardioactive 3-methyl-3-(3,4-dialkoxybenzyl)-piperazine compounds of the formula ##STR1## and their salts with physiologically tolerable acids; methods for making the same; pharmaceutical compositions containing the compounds as an active ingredient; and methods of treating cardiac diseases such as arrhythmia with said compounds.